Regional Practice Variation in the Management of Renal Replacement Therapy Modalities in the STARRT-AKI Trial
Blood Purification · 2025
DOI: 10.1159/000547141 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Blood Purification, 2025. Verfasst von Ary Serpa Neto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, …. Hauptthemen laut MEDLINE: Acute Kidney Injury, Continuous Renal Replacement Therapy, Renal Replacement Therapy. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
The assess whether, in high-income countries, in the STandard vs. Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial, the management of the chosen initial renal replacement therapy modality varied by region and whether such variation was associated with different outcomes.
Methods
Post hoc analysis of the STARRT-AKI trial, including 142 ICUs in 13 countries. We evaluated 1,395 patients with severe AKI from North America, Europe, and Australia-New Zealand (ANZ) who received continuous renal replacement therapy (CRRT) as a first modality and 684 patients from North America and Europe who received intermittent hemodialysis (IHD) as a first modality.
Results
Among CRRT-first patients, femoral vascular access (p < 0.001) and citrate anticoagulation were more common in Europe and ANZ (p < 0.001) before and after adjustment for baseline characteristics. Treatment in ANZ was independently associated with a more negative fluid balance (p = 0.029), less frequent transition to IHD (p = 0.040), and lower CRRT dose-intensity (p = 0.012). Among IHD-first patients, compared to Europe, treatment in North America was independently associated with less use of femoral access, and greater net ultrafiltration rate.
Conclusion
At STARRT-AKI trial centers, there was significant region-dependent practice variation in the management of CRRT-first and IHD-first patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
- Department of Critical Care, Melbourne Medical School, University of Melbourne, Austin Hospital, Melbourne, Victoria, Australia.
- Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.
- Department of Critical Care Medicine, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
- Data Analytics Research and Evaluation, Austin Hospital, Melbourne, Victoria, Australia.
- Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Zitieren
APA
Serpa Neto, A., Bellomo, R., Wald, R., Bagshaw, S. M., & STARRT-AKI Investigators (2025). Regional Practice Variation in the Management of Renal Replacement Therapy Modalities in the STARRT-AKI Trial. Blood Purification. https://doi.org/10.1159/000547141
Vancouver
Serpa Neto A, Bellomo R, Wald R, Bagshaw SM, STARRT-AKI Investigators. Regional Practice Variation in the Management of Renal Replacement Therapy Modalities in the STARRT-AKI Trial. Blood Purification. 2025. doi:10.1159/000547141
BibTeX
@article{SerpaNeto2025,
author = {Serpa Neto, Ary and Bellomo, Rinaldo and Wald, Ron and Bagshaw, Sean M and STARRT-AKI Investigators, STARRT-AKI Investigators},
title = {Regional Practice Variation in the Management of Renal Replacement Therapy Modalities in the STARRT-AKI Trial},
journal = {Blood Purification},
year = {2025},
doi = {10.1159/000547141}
}
EUVIMED